A rapid release tablet involves as an active ingredient tolfenamic acid or its pharmaceutically acceptable salts having a mean particle size of <10 μm, {HEAD ~ alginic acid} or its pharmaceutically acceptable salts in an amount of 1.5 6.0% by weight, and a superdisintegrant in an amount of {TAIL ~ at least 6%} by weight 
A rapid release tablet involves as an active ingredient tolfenamic acid or its pharmaceutically acceptable salts having a mean particle size of < 10 μm , { HEAD ~ alginic acid } or its pharmaceutically acceptable salts in an amount of 1.5 6.0 % by weight , and a superdisintegrant in an amount of { TAIL ~ at least 6 % } by weight
OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH TAIL TAIL TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH